BioDelivery Sciences International, Inc. (BDSI)
(Delayed Data from NSDQ)
$4.84 USD
+0.08 (1.68%)
Updated May 3, 2019 04:00 PM ET
After-Market: $4.85 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$4.84 USD
+0.08 (1.68%)
Updated May 3, 2019 04:00 PM ET
After-Market: $4.85 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
What Makes BioDelivery Sciences International (BDSI) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does BioDelivery Sciences International (BDSI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Protalix Finalizes Accelerated Approval Pathway for PRX-102
by Zacks Equity Research
Protalix (PLX) successfully completes the pre-BLA meeting and gets FDA acceptance for using accelerated approval pathway for the BLA submission of Fabry disease candidate, pegunigalsidase alfa.
BioDelivery (BDSI) Stock Up on Q3 Earnings Beat & Raised View
by Madhu Goel
BioDelivery (BDSI) beats earnings and sales expectations in the third quarter of 2019. The company raises its 2019 revenue guidance.
IVERIC bio (ISEE) Q3 Loss Narrows Y/Y, Zimura Advancing Well
by Zacks Equity Research
IVERIC bio's (ISEE) third-quarter earnings improve year over year. The company plans to initiate a pivotal study on Zimura for treating GA early next year.
5 Breakout Stocks for Explosive Returns
by Nitish Marwah
Picking breakout stocks is one of the most-favored methods for those utilizing an active investing approach since this strategy offers the promise of superlative returns.
BioDelivery Sciences International (BDSI) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
BioDelivery (BDSI) delivered earnings and revenue surprises of 400.00% and 5.01%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
BioDelivery Sciences International (BDSI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Unifi, BioDelivery Sciences International, Crocs, Anika Therapeutics and Plexus
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Unifi, BioDelivery Sciences International, Crocs, Anika Therapeutics and Plexus
Zacks.com featured highlights include: Universal Forest Products, BioDelivery Sciences International, CBIZ, Euronav and The Bancorp
by Zacks Equity Research
Zacks.com featured highlights include: Universal Forest Products, BioDelivery Sciences International, CBIZ, Euronav and The Bancorp
5 Stocks With Recent Price Strength to Enhance Your Return
by Nalak Das
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
5 Top Momentum Stocks in October That Still Have Upside Left
by Nalak Das
Possibility of at least an interim trade deal between the largest trading countries of the world boosted investors' confidence on risky assets like equities.
Here's Why Momentum Investors Will Love BioDelivery Sciences International (BDSI)
by Zacks Equity Research
Does BioDelivery Sciences International (BDSI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Moving Average Crossover Alert: BioDelivery Sciences International
by Zacks Equity Research
BioDelivery Sciences International, Inc. (BDSI) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Will BioDelivery Sciences Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor BioDelivery Sciences.
New Strong Buy Stocks for October 17th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
BioDelivery (BDSI) Up 8.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
BioDelivery (BDSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
BioDelivery (BDSI) Earnings & Sales Beat Estimates in Q2
by Zacks Equity Research
BioDelivery (BDSI) reports earnings against expectations of loss in Q2 and raises guidance for 2019.
Will BioDelivery Sciences International (BDSI) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
BioDelivery (BDSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Perrigo Completes Ranir Acquisition, Raises '19 Guidance
by Zacks Equity Research
Perrigo (PRGO) completes previously announced acquisition of Ranir. The company raised guidance for adjusted earnings to include accretion of 10 cents from Ranir.
Amarin (AMRN) Issues Update on Q2 Sales, Raises '19 Guidance
by Zacks Equity Research
Amarin announces strong preliminary sales of Vascepa in the second quarter. The company increases sales guidance for 2019.
Top Ranked Momentum Stocks to Buy for July 3rd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 3rd.
Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina
by Zacks Equity Research
Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina
Focus on 4 Liquid Picks on the Top Rung for Robust Returns
by Zacks Equity Research
Here are four top-ranked liquid stocks that investors can cling on to for significant returns.
What Makes BioDelivery (BDSI) a New Strong Buy Stock
by Zacks Equity Research
BioDelivery (BDSI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Middlesex Water, Atlantic Power, NexPoint Residential Trust, Illumina and BioDelivery Sciences International